| 000 | 01523 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513091858.0 | ||
| 264 | 0 | _c19960807 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0362-5664 | ||
| 024 | 7 |
_a10.1097/00002826-199502000-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhtila, S | |
| 245 | 0 | 0 |
_aEffect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteers. _h[electronic resource] |
| 260 |
_bClinical neuropharmacology _cFeb 1995 |
||
| 300 |
_a46-57 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCarbidopa _xpharmacokinetics |
| 650 | 0 | 4 |
_aCatechols _xpharmacology |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacokinetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xpharmacokinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 | _aReference Values |
| 700 | 1 | _aKaakkola, S | |
| 700 | 1 | _aGordin, A | |
| 700 | 1 | _aKorpela, K | |
| 700 | 1 | _aHeinävaara, S | |
| 700 | 1 | _aKarlsson, M | |
| 700 | 1 | _aWikberg, T | |
| 700 | 1 | _aTuomainen, P | |
| 700 | 1 | _aMännistö, P T | |
| 773 | 0 |
_tClinical neuropharmacology _gvol. 18 _gno. 1 _gp. 46-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002826-199502000-00006 _zAvailable from publisher's website |
| 999 |
_c8663853 _d8663853 |
||